Position in INVA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,851,966
+$2,741,242 QoQ
Shares Held
122,402
+2109.8% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
3.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Dauntless Investment Group, LLC holds $15,262,700 across 23 Biotechnology names. INVA ranks #1 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INVA |
Innoviva, Inc.
This page
|
122,402 | $2,851,966 | |
| 2 | TLSA |
Tiziana Life Sciences Ltd
|
2,165,231 | $2,533,320 | |
| 3 | AEON |
AEON Biopharma, Inc.
|
2,527,775 | $2,489,858 | |
| 4 | QNRX |
Quoin Pharmaceuticals, Ltd.
|
196,592 | $1,297,507 | |
| 5 | UNCY |
Unicycive Therapeutics, Inc.
|
147,087 | $967,832 | |
| 6 | ARMP |
Armata Pharmaceuticals, Inc.
|
90,580 | $927,539 | |
| 7 | TRAW |
Traws Pharma, Inc.
|
416,998 | $763,106 | |
| 8 | KZIA |
Kazia Therapeutics Ltd
|
79,832 | $593,950 |
All Filings in INVA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,851,966 | 122,402 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $110,724 | 5,539 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||